U.S. Appeals Court Rules For Natco, Mylan In MS Drug Patent Case
This article was originally published in PharmAsia News
Executive Summary
Natco Pharma said it has won a U.S. appeals court decision allowing it and its marketing partner, Mylan Laboratories, to launch its generic of Copaxone (glatiramer) multiple sclerosis drug of Teva Pharmaceuticals beginning next May.